You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 139 No. 3, March 2003 TABLE OF CONTENTS
  Archives
  •  Online Features
  Study
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on ISI (11)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Psoriasis
 •Phototherapy
 •Alert me on articles by topic

Narrowband UV-B (TL-01) Phototherapy vs Oral 8-Methoxypsoralen Psoralen–UV-A for the Treatment of Chronic Plaque Psoriasis

T. Markham, MB, MRCPI; S. Rogers, MSc, FRCP(London), FRCPI, FRCP(Edin); P. Collins, MD, FRCPI, DCh

Arch Dermatol. 2003;139:325-328.

Objective  To compare the efficacy of narrowband UV-B (TL-01) phototherapy with oral 8-methoxypsoralen photochemotherapy (8-MOP psoralen–UV-A [PUVA]) in patients with chronic plaque psoriasis (CPP).

Design  Open, randomized, controlled study.

Setting  Phototherapy unit in a dermatology hospital.

Patients  Fifty-four patients with CCP.

Interventions  Patients received whole-body threshold erythemogenic dose of either 3-times weekly TL-01 or twice-weekly oral 8-MOP PUVA, based on minimal erythema or phototoxic doses. Patients were treated until completely clear.

Outcome Measures  Number of treatments to clear, number of days in treatment, number of days in remission, and adverse effects of both therapies were assessed.

Results  Forty-five patients completed the study. Those in the PUVA group required significantly fewer treatments to clear (P = .03). There was no significant difference in the number of days to clear or number of days in remission. A similar percentage of patients in the TL-01 and PUVA groups developed minimal perceptible erythema, showing that the regimens were equally erythemogenic. Asymptomatic, well-defined erythema occurred only in the PUVA group. Pruritus and polymorphic light eruption occurred equally in both groups, but only patients in the PUVA group developed nausea.

Conclusion  Narrowband UV-B phototherapy, used 3 times weekly, is as effective for the treatment of CPP as oral 8-MOP PUVA used twice weekly.


From the City of Dublin Skin and Cancer Hospital, Dublin, Ireland. The authors have no relevant financial interest in this article.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Randomized Double-blind Trial of the Treatment of Chronic Plaque Psoriasis: Efficacy of Psoralen-UV-A Therapy vs Narrowband UV-B Therapy.
Yones et al.
Arch Dermatol 2006;142:836-842.
ABSTRACT | FULL TEXT  

Narrowband UVB vs. PUVA in Chronic Plaque Psoriasis
Journal Watch Dermatology 2003;2003:3-3.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.